Atlas Trials

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Clinical trial NCT00822393 · COMPLETED

Trial details

NCT number
NCT00822393
Sponsor
medac GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Start date
2008-11-24
Primary completion
2018-01-25
Enrollment
570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.